| Literature DB >> 36035939 |
Xiaoli Zhao1, Guifang Huang2, Lin Wu1, Min Wang1, Xuemin He3, Jyun-Rong Wang4,5, Bin Zhou1, Yong Liu1, Yesheng Lin1, Dinghui Liu1, Xianguan Yu1, Suzhen Liang1, Borui Tian1, Linxiao Liu1, Yanming Chen3, Shuhong Qiu2, Xujing Xie1, Lanqing Han6, Xiaoxian Qian1.
Abstract
Background: Current electrocardiogram (ECG) criteria of left ventricular hypertrophy (LVH) have low sensitivity. Deep learning (DL) techniques have been widely used to detect cardiac diseases due to its ability of automatic feature extraction of ECG. However, DL was rarely applied in LVH diagnosis. Our study aimed to construct a DL model for rapid and effective detection of LVH using 12-lead ECG.Entities:
Keywords: convolutional neural network-long short-term memory; deep learning model; echocardiography; electrocardiogram; left ventricular hypertrophy
Year: 2022 PMID: 36035939 PMCID: PMC9406285 DOI: 10.3389/fcvm.2022.952089
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Figure 1Study flow diagram. (A) The first cohort was further divided into training, validation and test sets. (B) The second cohort was used as internal test 2 to evaluate developed DL model.
Patient characteristics between LVH and control groups.
|
|
|
|
|
|---|---|---|---|
|
|
| ||
|
| |||
| Female, | 511 (54.8) | 273 (29.3) | <0.001 |
| Age, years | 67.3 (10.5) | 63.9 (11.3) | <0.001 |
|
| |||
| CAD, | 601 (64.5) | 564 (60.6) | 0.082 |
| HT, | 586 (62.9) | 486 (52.2) | <0.001 |
| CHF, | 330 (35.4) | 223 (24.0) | <0.001 |
| DM, | 306 (32.8) | 333 (35.8) | 0.182 |
| Stroke, | 129 (13.8) | 122 (13.1) | 0.641 |
| CKD, | 85 (9.1) | 47 (5.0) | 0.001 |
| STEMI, | 23 (2.5) | 16 (1.7) | 0.259 |
|
| |||
| HDL-C (mmol/L) | 1.07 (0.29) | 1.04 (0.27) | 0.270 |
| LDL-C (mmol/L) | 2.77 (1.06) | 2.82 (1.03) | 1.030 |
| HGB (g/L) | 125.71 (19.06) | 133.02 (18.74) | <0.001 |
| PLT (10∧9/L) | 230.52 (85.34) | 228.64 (68.03) | 0.607 |
| BUN (mmol/L) | 6.82 (4.58) | 6.16 (2.70) | <0.001 |
| Cr (umol/L) | 103.92 (122.34) | 87.81 (58.00) | <0.001 |
| UA (umol/L) | 394.94 (124.77) | 394.92 (112.51) | 0.997 |
| potassium (mmol/L) | 3.99 (0.45) | 4.00 (0.40) | 0.620 |
| sodium (mmol/L) | 141.58 (3.24) | 141.39 (5.17) | 0.767 |
|
| |||
| RV5 (mV) | 1.49 (1.12, 1.99) | 1.40 (1.09, 1.75) | <0.001 |
| RV6 (mV) | 1.20 (0.87, 1.58) | 1.10 (0.86, 1.42) | <0.001 |
| RaVL (mV) | 0.42 (0.24, 0.63) | 0.33 (0.17, 0.54) | <0.001 |
| SV1 (mV) | −0.81 (−1.12 to −0.53) | −0.72 (−0.97 to −0.50) | <0.001 |
| SV3 (mV) | −0.93 (−1.32 to −0.58) | −0.86 (−1.17 to −0.55) | 0.002 |
| Cornell voltage LVH, | 414 (45.2) | 240 (26.3) | <0.001 |
| Sokolow-Lyon LVH, | 109 (11.9) | 18 (2.0) | <0.001 |
|
| |||
| LVEF (%) | 64.08 (9.35) | 67.43 (5.17) | <0.001 |
| LVEDD (mm) | 49.23 (5.34) | 44.6 (3.97) | <0.001 |
| LVPW (mm) | 10.44 (1.10) | 9.58 (1.01) | <0.001 |
| IVS (mm) | 11.77 (1.68) | 10.50 (1.34) | <0.001 |
| LVMI (g/m2) | 129.28 (28.93) | 89.97 (14.47) | <0.001 |
| Concentric LVH, | 515 (55.3) | 532 (57.1) | 0.412 |
|
| |||
| ACEI, | 192 (20.6) | 113 (12.1) | <0.001 |
| ARB, | 264 (28.3) | 234 (25.1) | 0.120 |
| Spirolactone, | 134 (14.4) | 107 (11.5) | 0.064 |
| CCB, | 366 (39.3) | 326 (35.0) | 0.057 |
| BB, | 586 (62.9) | 563 (60.5) | 0.286 |
| Diuretics, | 240 (25.8) | 186 (20.0) | 0.003 |
CAD, coronary artery disease; HT, hypertension; DM, diabetes mellitus; CHF, chronic heart failure; CKD, chronic kidney disease; STEMI, ST-segment elevation myocardial infarction; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; HGB, hemoglobin; PLT, platelet; BUN, blood urea nitrogen; Cr, creatinine; UA, uric acid; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic dimension; LVPW, left ventricle posterior wall; IVS, ventricular septum; LVMI, left ventricular mass index; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; BB, beta-block.
Figure 2Receiver operating characteristic curve analysis, (A) compared the DL model with Cornell voltage and Sokolow-Lyon voltage in test set 1, the confusion matrix for predicting control and LVH using the DL model in the test set 1; (B) to test the DL model in internal test set 2. DL, deep learning model; CV, Cornell voltage, SL, Sokolow-Lyon voltage.
Figure 3Comparing the DL model with Cornell voltage and Sokolow-Lyon voltage to predict LVH, the confusion matrix for predicting control and LVH using the DL model in the test set; (A) for male patients; (B) for female patients. DL, deep learning model; CV, Cornell voltage; SL, Sokolow-Lyon voltage.
Figure 4Receiver operating characteristic curve analysis of different models according to gender and relative wall thickness (Model 1: Control-M vs. concentric LVH-M; Model 2: Control-M vs. eccentric LVH-M; Model 3: Control-F vs. concentric LVH-F; Model 4: Control-F vs. eccentric LVH-F). LVH-F, female patients with left ventricular hypertrophy; LVH-M, male patients with left ventricular hypertrophy; Control-F, female patients in control group; Control-M, male patients in control group.